Lynch & Associates Agenus Inc Transaction History
Lynch & Associates
- $429 Million
- Q1 2024
A detailed history of Lynch & Associates transactions in Agenus Inc stock. As of the latest transaction made, Lynch & Associates holds 58,600 shares of AGEN stock, worth $978,034. This represents 0.01% of its overall portfolio holdings.
Number of Shares
58,600
Previous 42,600
37.56%
Holding current value
$978,034
Previous $35,000
5.71%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding AGEN
# of Institutions
128Shares Held
205MCall Options Held
1.18MPut Options Held
69.8K-
Vanguard Group Inc Valley Forge, PA34.4MShares$574 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT31.7MShares$529 Million0.61% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct30.1MShares$503 Million0.04% of portfolio
-
Black Rock Inc. New York, NY29.2MShares$488 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N415.6MShares$261 Million0.49% of portfolio
About AGENUS INC
- Ticker AGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 283,163,008
- Market Cap $4.73B
- Description
- Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...